{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-027808","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.819308+00:00","generated_at":"2026-06-01T07:46:59.140902+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"ProKidney provides final Phase 2 RMCL-002 data; specifics not in filing text","bullets":["Company furnished investor presentation with final data from Phase 2 RMCL-002 clinical trial.","Presentation available on ProKidney's website; full data not included in 8-K excerpt.","Trial targets dialysis prevention; efficacy/safety figures not disclosed in filing.","No financial or operational updates beyond the trial data release."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-027808","json":"https://secwatch.observer/filing/0001140361-24-027808.json","markdown":"https://secwatch.observer/filing/0001140361-24-027808.md","text":"https://secwatch.observer/filing/0001140361-24-027808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124027808/0001140361-24-027808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124027808/ef20030179_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:46:59.140902+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}